SCHEMBL9722906

SCHEMBL9722906

c1c(N2CC[N]CC2)nc(N2CCOCC2)nc1N1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.65
NPSR1 Q6W5P4 1/20 0.56
HRH4 Q9H3N8 1/20 0.56
PIK3CA P42336 5/20 0.52
MAP3K12 Q12852 1/20 0.52
HTT P42858 2/20 0.50
PIK3CB P42338 1/20 0.50
KDM4E B2RXH2 3/20 0.49
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
GAA P10253 2/20 0.49
THRB P10828 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MTOR P42345 3/20 0.48
CASP1 P29466 1/20 0.47
CASP4 P49662 1/20 0.47
CASP5 P51878 1/20 0.47
MAPT P10636 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9003193 0.91 KMT2A (0.76) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL9640164 0.85 KMT2A (0.69) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL9640988 0.85 KMT2A (0.69) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL9639621 0.84 KMT2A (0.67) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL9722891 0.83 CASP1 (0.67) KMT2AHRH4SMN1; SMN2CASP1CASP4
SCHEMBL9069830 0.82 CASP1 (0.71) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL1123988 0.79 KMT2A (0.61) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL1123993 0.79 KMT2A (0.61) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL3289509 0.79 KMT2A (0.65) KMT2ANPSR1HRH4PIK3CAMAP3K12
SCHEMBL855348 0.79 MAPT (0.68) KMT2ANPSR1HRH4PIK3CAMAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175281-A Antiulcer, antiinflammatory, antiischemic, antiallergen, antisecretory, wound healing agents; cardiovascular disorders THE UPJOHN COMPANY (US) 1992-12-29 US claimed
EP-0354920-A1 AMINO-9,10-SECOSTEROIDS THE UPJOHN COMPANY (US) 1990-02-21 EP claimed
WO-1988007527-A1 AMINO-9,10-SECOSTEROIDS THE UPJOHN COMPANY (US) 1988-10-06 WO claimed
EP-0263213-A1 C20 Through C26 amino steroids THE UPJOHN COMPANY (US) 1988-04-13 EP claimed
EP-0238545-A1 C 20? THROUGH C 26? AMINO STEROIDS. UPJOHN CO (US) 1987-09-30 EP claimed
WO-1987001706-A2 C20 THROUGH C26 AMINO STEROIDS THE UPJOHN COMPANY (US) 1987-03-26 WO claimed
US-4996318-A Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke THE UPJOHN COMPANY (US) 1991-02-26 US disclosed
EP-0354920-A1 AMINO-9,10-SECOSTEROIDS THE UPJOHN COMPANY (US) 1990-02-21 EP disclosed
WO-1988007527-A1 AMINO-9,10-SECOSTEROIDS THE UPJOHN COMPANY (US) 1988-10-06 WO disclosed